INmune Bio Inc. short interest in 2025
In 2025, INmune Bio Inc.'s disclosed short interest ran from 22.70% of shares outstanding on 15 Jan 2025 to 12.19% on 31 Dec 2025, a change of -10.51 percentage points. The year's high was 44.94% on 30 Jun 2025 and its low 11.76% on 28 Nov 2025, averaging 21.29% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.21 days on 14 Mar 2025. Full history: INmune Bio Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 22.70% (15 Jan 2025)
- End of year
- 12.19% (31 Dec 2025)
- Change
- -10.51 pp
- High
- 44.94% (30 Jun 2025)
- Low
- 11.76% (28 Nov 2025)
- Average
- 21.29%
- Highest days to cover
- 26.21 (14 Mar 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 22.70% | 10.51 | |
| 31 Jan 2025 | 24.85% | 10.47 | |
| 14 Feb 2025 | 24.33% | 11.04 | |
| 28 Feb 2025 | 24.43% | 19.79 | |
| 14 Mar 2025 | 25.15% | 26.21 | |
| 31 Mar 2025 | 26.43% | 20.24 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 26.09% | 21.84 | |
| 30 Apr 2025 | 25.41% | 25.36 | |
| 15 May 2025 | 25.29% | 25.21 | 10-Q filed, results (8-K) |
| 30 May 2025 | 26.62% | 20.45 | |
| 13 Jun 2025 | 31.27% | 11.62 | |
| 30 Jun 2025 | 44.94% | 1.00 | |
| 15 Jul 2025 | 23.81% | 1.70 | |
| 31 Jul 2025 | 25.78% | 2.30 | |
| 15 Aug 2025 | 20.05% | 1.81 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.06% | 4.50 | |
| 15 Sep 2025 | 12.51% | 3.90 | |
| 30 Sep 2025 | 12.34% | 6.62 | |
| 15 Oct 2025 | 13.08% | 8.94 | |
| 31 Oct 2025 | 12.01% | 9.62 | 10-Q filed, results (8-K) |
| 14 Nov 2025 | 12.98% | 9.87 | |
| 28 Nov 2025 | 11.76% | 7.71 | |
| 15 Dec 2025 | 12.86% | 5.52 | |
| 31 Dec 2025 | 12.19% | 8.74 |
See also: INmune Bio Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.